Illustrative image (Photo: VNA) Hanoi (VNA) – are expected to meet
75 percent of demand and 60 percent of market value by 2025, according to a
programme on the development of the pharmaceutical industry and medicines for
domestic production till 2030 with a vision to 2045.
Recently approved by the Prime Minister, the programme set the
overall goal of building the to level 4
according to the (WHO)’s classification, the top 3 in
terms of market value in ASEAN, contributing to ensuring the timely and
sufficient supply of safe, quality and effective medicines at reasonable
prices.
It also targets developing medicines into a quality and high-value
industry that is competitive at home and abroad.
By 2025, the rate of using pharmaceuticals of domestic origin will increase by
at least 10 percent from 2020.
At the same time, Vietnam will build eight zones for sustainable
exploitation of natural medicinal sources, two to five cultivation areas on a large scale. Each of
them will have one to two linkage chains of research, farming and processing following
the WHO’s Guidelines on Good Agricultural and Collection Practices.
By early 2030, Vietnam sets to become a pharmaceutical
production hub in the region with a total value of nearly 1 billion USD.
To such end, the programme also set out measures regarding
institutions, laws, investment, competitiveness improvement, science-technology,
workforce training, control of medicine and pharmaceutical market,
international cooperation and integration, information and communications.
Accordingly, at least two national-level science-technology
tasks using the State budget will be performed in three years while at least
five ministry-level pharmaceutical development tasks will be undertaken in one
year, focusing on research and production of vaccines as well as national
products using domestic medicinal sources./.
Source: VietnamPlus
